CLNN - Clene to Present at the Emerging Growth Conference | Benzinga
SALT LAKE CITY, July 12, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that management will present at the Emerging Growth Conference.
Virtual Presentation Details
Date: July 18, 2024
Time of Presentation: 4:45 p.m. EDT
Format: Corporate update with Q&A
A webcast of the presentation will be available on the "Events" section of the Clene website. Alternatively, one can register for and view the webcast, along with accompanying slides, here: https://goto.webcasts.com/starthere.jsp?ei=1670756&tp_key=e579348dea&sti=clnn. A replay of the presentation will also be available through the conference portal and the Emerging Growth ...